Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis

Control of cutaneous leishmaniasis (CL) in the Americas is dependent on chemotherapy with parenteral pentavalent antimonials. High rates of treatment failure urge the search for predictive and prognostic markers of therapeutic responsiveness. In this study, we aimed to identify biomarkers of therape...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Pharmacol
Huvudupphovsmän: Vargas, Deninson Alejandro, Prieto, Miguel Dario, Martínez-Valencia, Alvaro José, Cossio, Alexandra, Burgess, Karl E. V., Burchmore, Richard J.S., Gómez, María Adelaida
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2019
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595045/
https://ncbi.nlm.nih.gov/pubmed/31281253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00657
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk